nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.421	0.598	CbGaD
Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.283	0.402	CbGaD
Chlorpromazine—SMPD1—urine—polycystic ovary syndrome	0.00709	0.0995	CbGeAlD
Chlorpromazine—SLC22A1—Metformin—polycystic ovary syndrome	0.00277	1	CbGbCtD
Chlorpromazine—CYP1A2—urine—polycystic ovary syndrome	0.002	0.0281	CbGeAlD
Chlorpromazine—CYP2E1—urine—polycystic ovary syndrome	0.0018	0.0253	CbGeAlD
Chlorpromazine—HTR2A—urine—polycystic ovary syndrome	0.00157	0.022	CbGeAlD
Chlorpromazine—SMPD1—adipose tissue—polycystic ovary syndrome	0.00151	0.0212	CbGeAlD
Chlorpromazine—CYP3A4—urine—polycystic ovary syndrome	0.00145	0.0203	CbGeAlD
Chlorpromazine—CYP2D6—urine—polycystic ovary syndrome	0.00143	0.02	CbGeAlD
Chlorpromazine—SMPD1—adrenal gland—polycystic ovary syndrome	0.00136	0.019	CbGeAlD
Chlorpromazine—SMPD1—female gonad—polycystic ovary syndrome	0.00126	0.0177	CbGeAlD
Chlorpromazine—SMPD1—vagina—polycystic ovary syndrome	0.00126	0.0176	CbGeAlD
Chlorpromazine—SMPD1—endocrine gland—polycystic ovary syndrome	0.00118	0.0165	CbGeAlD
Chlorpromazine—DRD5—female gonad—polycystic ovary syndrome	0.000937	0.0132	CbGeAlD
Chlorpromazine—ABCB11—endocrine gland—polycystic ovary syndrome	0.00093	0.0131	CbGeAlD
Chlorpromazine—DRD5—endocrine gland—polycystic ovary syndrome	0.000872	0.0122	CbGeAlD
Chlorpromazine—CALM3—adrenal cortex—polycystic ovary syndrome	0.000871	0.0122	CbGeAlD
Chlorpromazine—CALM2—embryo—polycystic ovary syndrome	0.000834	0.0117	CbGeAlD
Chlorpromazine—CALM1—embryo—polycystic ovary syndrome	0.00083	0.0117	CbGeAlD
Chlorpromazine—CALM3—endometrium—polycystic ovary syndrome	0.000777	0.0109	CbGeAlD
Chlorpromazine—HTR2B—adrenal cortex—polycystic ovary syndrome	0.000776	0.0109	CbGeAlD
Chlorpromazine—CALM3—uterus—polycystic ovary syndrome	0.000716	0.0101	CbGeAlD
Chlorpromazine—CALM3—pituitary gland—polycystic ovary syndrome	0.000704	0.00988	CbGeAlD
Chlorpromazine—CALM3—adipose tissue—polycystic ovary syndrome	0.000701	0.00984	CbGeAlD
Chlorpromazine—HTR2B—endometrium—polycystic ovary syndrome	0.000693	0.00973	CbGeAlD
Chlorpromazine—CALM2—adrenal cortex—polycystic ovary syndrome	0.000684	0.0096	CbGeAlD
Chlorpromazine—CALM1—adrenal cortex—polycystic ovary syndrome	0.000681	0.00956	CbGeAlD
Chlorpromazine—SLC22A1—adipose tissue—polycystic ovary syndrome	0.000678	0.00952	CbGeAlD
Chlorpromazine—HTR2B—uterus—polycystic ovary syndrome	0.000639	0.00897	CbGeAlD
Chlorpromazine—CALM3—adrenal gland—polycystic ovary syndrome	0.000628	0.00882	CbGeAlD
Chlorpromazine—HTR2B—adipose tissue—polycystic ovary syndrome	0.000625	0.00877	CbGeAlD
Chlorpromazine—CALM2—endometrium—polycystic ovary syndrome	0.000611	0.00857	CbGeAlD
Chlorpromazine—CALM1—endometrium—polycystic ovary syndrome	0.000608	0.00853	CbGeAlD
Chlorpromazine—CALM3—female gonad—polycystic ovary syndrome	0.000586	0.00823	CbGeAlD
Chlorpromazine—CALM3—vagina—polycystic ovary syndrome	0.000582	0.00818	CbGeAlD
Chlorpromazine—ALB—adrenal gland—polycystic ovary syndrome	0.000582	0.00817	CbGeAlD
Chlorpromazine—Propericiazine—ADRA1B—polycystic ovary syndrome	0.000577	0.0943	CrCbGaD
Chlorpromazine—SLC22A1—vagina—polycystic ovary syndrome	0.000563	0.00791	CbGeAlD
Chlorpromazine—CALM2—uterus—polycystic ovary syndrome	0.000563	0.0079	CbGeAlD
Chlorpromazine—CHRM3—adipose tissue—polycystic ovary syndrome	0.000562	0.00789	CbGeAlD
Chlorpromazine—HTR2B—adrenal gland—polycystic ovary syndrome	0.00056	0.00787	CbGeAlD
Chlorpromazine—CALM1—uterus—polycystic ovary syndrome	0.00056	0.00786	CbGeAlD
Chlorpromazine—KCNH2—endometrium—polycystic ovary syndrome	0.000553	0.00777	CbGeAlD
Chlorpromazine—CALM2—pituitary gland—polycystic ovary syndrome	0.000552	0.00776	CbGeAlD
Chlorpromazine—CALM2—adipose tissue—polycystic ovary syndrome	0.00055	0.00773	CbGeAlD
Chlorpromazine—CALM1—pituitary gland—polycystic ovary syndrome	0.00055	0.00772	CbGeAlD
Chlorpromazine—CALM1—adipose tissue—polycystic ovary syndrome	0.000548	0.00769	CbGeAlD
Chlorpromazine—CHRM2—endocrine gland—polycystic ovary syndrome	0.000537	0.00754	CbGeAlD
Chlorpromazine—SLC22A1—endocrine gland—polycystic ovary syndrome	0.000527	0.0074	CbGeAlD
Chlorpromazine—HTR2B—vagina—polycystic ovary syndrome	0.000519	0.00729	CbGeAlD
Chlorpromazine—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000516	0.00725	CbGeAlD
Chlorpromazine—KCNH2—uterus—polycystic ovary syndrome	0.00051	0.00716	CbGeAlD
Chlorpromazine—BCHE—endometrium—polycystic ovary syndrome	0.000509	0.00715	CbGeAlD
Chlorpromazine—DRD2—pituitary gland—polycystic ovary syndrome	0.000508	0.00713	CbGeAlD
Chlorpromazine—HTR2A—embryo—polycystic ovary syndrome	0.000506	0.0071	CbGeAlD
Chlorpromazine—HTR1A—adrenal gland—polycystic ovary syndrome	0.000502	0.00705	CbGeAlD
Chlorpromazine—KCNH2—pituitary gland—polycystic ovary syndrome	0.0005	0.00703	CbGeAlD
Chlorpromazine—CALM2—adrenal gland—polycystic ovary syndrome	0.000494	0.00693	CbGeAlD
Chlorpromazine—CALM1—adrenal gland—polycystic ovary syndrome	0.000491	0.0069	CbGeAlD
Chlorpromazine—CHRM1—endocrine gland—polycystic ovary syndrome	0.000489	0.00686	CbGeAlD
Chlorpromazine—HTR7—adrenal gland—polycystic ovary syndrome	0.00048	0.00674	CbGeAlD
Chlorpromazine—CHRM3—female gonad—polycystic ovary syndrome	0.00047	0.0066	CbGeAlD
Chlorpromazine—BCHE—uterus—polycystic ovary syndrome	0.000469	0.00659	CbGeAlD
Chlorpromazine—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000463	0.0065	CbGeAlD
Chlorpromazine—BCHE—pituitary gland—polycystic ovary syndrome	0.000461	0.00647	CbGeAlD
Chlorpromazine—CALM2—female gonad—polycystic ovary syndrome	0.00046	0.00646	CbGeAlD
Chlorpromazine—BCHE—adipose tissue—polycystic ovary syndrome	0.000459	0.00644	CbGeAlD
Chlorpromazine—CALM1—female gonad—polycystic ovary syndrome	0.000458	0.00643	CbGeAlD
Chlorpromazine—CALM2—vagina—polycystic ovary syndrome	0.000457	0.00642	CbGeAlD
Chlorpromazine—CALM1—vagina—polycystic ovary syndrome	0.000455	0.00639	CbGeAlD
Chlorpromazine—KCNH2—adrenal gland—polycystic ovary syndrome	0.000447	0.00628	CbGeAlD
Chlorpromazine—HRH1—endometrium—polycystic ovary syndrome	0.000443	0.00622	CbGeAlD
Chlorpromazine—CHRM3—endocrine gland—polycystic ovary syndrome	0.000437	0.00614	CbGeAlD
Chlorpromazine—HTR1A—endocrine gland—polycystic ovary syndrome	0.000435	0.00611	CbGeAlD
Chlorpromazine—ADRA2A—endometrium—polycystic ovary syndrome	0.000435	0.00611	CbGeAlD
Chlorpromazine—CALM2—endocrine gland—polycystic ovary syndrome	0.000428	0.00601	CbGeAlD
Chlorpromazine—CALM1—endocrine gland—polycystic ovary syndrome	0.000426	0.00598	CbGeAlD
Chlorpromazine—KCNH2—female gonad—polycystic ovary syndrome	0.000417	0.00585	CbGeAlD
Chlorpromazine—HTR7—endocrine gland—polycystic ovary syndrome	0.000416	0.00584	CbGeAlD
Chlorpromazine—KCNH2—vagina—polycystic ovary syndrome	0.000414	0.00582	CbGeAlD
Chlorpromazine—BCHE—adrenal gland—polycystic ovary syndrome	0.000412	0.00578	CbGeAlD
Chlorpromazine—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000401	0.00564	CbGeAlD
Chlorpromazine—ADRA2A—uterus—polycystic ovary syndrome	0.000401	0.00563	CbGeAlD
Chlorpromazine—HRH1—adipose tissue—polycystic ovary syndrome	0.000399	0.00561	CbGeAlD
Chlorpromazine—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000394	0.00553	CbGeAlD
Chlorpromazine—DRD2—endocrine gland—polycystic ovary syndrome	0.000393	0.00553	CbGeAlD
Chlorpromazine—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000392	0.00551	CbGeAlD
Chlorpromazine—KCNH2—endocrine gland—polycystic ovary syndrome	0.000388	0.00544	CbGeAlD
Chlorpromazine—BCHE—vagina—polycystic ovary syndrome	0.000381	0.00536	CbGeAlD
Chlorpromazine—Acepromazine—ADRA1B—polycystic ovary syndrome	0.000371	0.0606	CrCbGaD
Chlorpromazine—Thioproperazine—ADRA1B—polycystic ovary syndrome	0.000363	0.0592	CrCbGaD
Chlorpromazine—HRH1—adrenal gland—polycystic ovary syndrome	0.000358	0.00503	CbGeAlD
Chlorpromazine—BCHE—endocrine gland—polycystic ovary syndrome	0.000357	0.00501	CbGeAlD
Chlorpromazine—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000352	0.00494	CbGeAlD
Chlorpromazine—Propiomazine—ADRA1D—polycystic ovary syndrome	0.000348	0.0567	CrCbGaD
Chlorpromazine—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000344	0.00484	CbGeAlD
Chlorpromazine—HTR2A—pituitary gland—polycystic ovary syndrome	0.000335	0.0047	CbGeAlD
Chlorpromazine—HRH1—female gonad—polycystic ovary syndrome	0.000334	0.00469	CbGeAlD
Chlorpromazine—HRH1—vagina—polycystic ovary syndrome	0.000332	0.00466	CbGeAlD
Chlorpromazine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000332	0.00466	CbGeAlD
Chlorpromazine—ABCB1—embryo—polycystic ovary syndrome	0.000332	0.00466	CbGeAlD
Chlorpromazine—ADRA2A—female gonad—polycystic ovary syndrome	0.000328	0.00461	CbGeAlD
Chlorpromazine—ADRA2A—vagina—polycystic ovary syndrome	0.000326	0.00458	CbGeAlD
Chlorpromazine—HRH1—endocrine gland—polycystic ovary syndrome	0.000311	0.00436	CbGeAlD
Chlorpromazine—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000305	0.00429	CbGeAlD
Chlorpromazine—HTR2A—adrenal gland—polycystic ovary syndrome	0.000299	0.0042	CbGeAlD
Chlorpromazine—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000299	0.00419	CbGeAlD
Chlorpromazine—Methotrimeprazine—ADRA1D—polycystic ovary syndrome	0.000297	0.0485	CrCbGaD
Chlorpromazine—Propiomazine—ADRA1B—polycystic ovary syndrome	0.000297	0.0484	CrCbGaD
Chlorpromazine—Zuclopenthixol—ADRA1A—polycystic ovary syndrome	0.000279	0.0455	CrCbGaD
Chlorpromazine—HTR2A—vagina—polycystic ovary syndrome	0.000277	0.00389	CbGeAlD
Chlorpromazine—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000272	0.00382	CbGeAlD
Chlorpromazine—Thioridazine—ADRA1B—polycystic ovary syndrome	0.000266	0.0434	CrCbGaD
Chlorpromazine—HTR2A—endocrine gland—polycystic ovary syndrome	0.00026	0.00364	CbGeAlD
Chlorpromazine—Trimipramine—ADRA1B—polycystic ovary syndrome	0.000259	0.0424	CrCbGaD
Chlorpromazine—Promazine—ADRA1D—polycystic ovary syndrome	0.000258	0.0421	CrCbGaD
Chlorpromazine—CYP2D6—female gonad—polycystic ovary syndrome	0.000254	0.00357	CbGeAlD
Chlorpromazine—Methotrimeprazine—ADRA1B—polycystic ovary syndrome	0.000254	0.0414	CrCbGaD
Chlorpromazine—Acepromazine—ADRA1A—polycystic ovary syndrome	0.00025	0.0408	CrCbGaD
Chlorpromazine—Thioproperazine—ADRA1A—polycystic ovary syndrome	0.000244	0.0398	CrCbGaD
Chlorpromazine—ABCB1—endometrium—polycystic ovary syndrome	0.000243	0.00341	CbGeAlD
Chlorpromazine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00024	0.00337	CbGeAlD
Chlorpromazine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000236	0.00332	CbGeAlD
Chlorpromazine—Imipramine—ADRA1D—polycystic ovary syndrome	0.000226	0.0368	CrCbGaD
Chlorpromazine—ABCB1—uterus—polycystic ovary syndrome	0.000224	0.00314	CbGeAlD
Chlorpromazine—Promazine—ADRA1B—polycystic ovary syndrome	0.00022	0.0359	CrCbGaD
Chlorpromazine—ABCB1—pituitary gland—polycystic ovary syndrome	0.00022	0.00308	CbGeAlD
Chlorpromazine—ABCB1—adipose tissue—polycystic ovary syndrome	0.000219	0.00307	CbGeAlD
Chlorpromazine—Propiomazine—ADRA1A—polycystic ovary syndrome	0.0002	0.0326	CrCbGaD
Chlorpromazine—ABCB1—adrenal gland—polycystic ovary syndrome	0.000196	0.00275	CbGeAlD
Chlorpromazine—Imipramine—ADRA1B—polycystic ovary syndrome	0.000192	0.0314	CrCbGaD
Chlorpromazine—ABCB1—female gonad—polycystic ovary syndrome	0.000183	0.00257	CbGeAlD
Chlorpromazine—ABCB1—vagina—polycystic ovary syndrome	0.000182	0.00255	CbGeAlD
Chlorpromazine—Thioridazine—ADRA1A—polycystic ovary syndrome	0.000179	0.0292	CrCbGaD
Chlorpromazine—Trimipramine—ADRA1A—polycystic ovary syndrome	0.000175	0.0285	CrCbGaD
Chlorpromazine—Methotrimeprazine—ADRA1A—polycystic ovary syndrome	0.000171	0.0279	CrCbGaD
Chlorpromazine—ABCB1—endocrine gland—polycystic ovary syndrome	0.00017	0.00239	CbGeAlD
Chlorpromazine—Promethazine—ADRA1A—polycystic ovary syndrome	0.000168	0.0275	CrCbGaD
Chlorpromazine—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.000166	0.0271	CrCbGaD
Chlorpromazine—Promazine—ADRA1A—polycystic ovary syndrome	0.000148	0.0242	CrCbGaD
Chlorpromazine—Imipramine—ADRA1A—polycystic ovary syndrome	0.00013	0.0211	CrCbGaD
Chlorpromazine—Desipramine—ADRB2—polycystic ovary syndrome	9.08e-05	0.0148	CrCbGaD
Chlorpromazine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	3.15e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	3.15e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—INS—polycystic ovary syndrome	3.15e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—INS—polycystic ovary syndrome	3.15e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.14e-06	1.46e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	3.12e-06	1.45e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.11e-06	1.45e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.11e-06	1.45e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	3.1e-06	1.44e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	3.09e-06	1.44e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	3.09e-06	1.44e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	3.08e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—NRG1—polycystic ovary syndrome	3.08e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	3.08e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	3.08e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	3.08e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling by GPCR—IL6—polycystic ovary syndrome	3.07e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling by GPCR—IL6—polycystic ovary syndrome	3.07e-06	1.43e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.06e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	3.06e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.06e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	3.05e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—IL6—polycystic ovary syndrome	3.05e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—INS—polycystic ovary syndrome	3.05e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—INS—polycystic ovary syndrome	3.05e-06	1.42e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	3.05e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—AKT2—polycystic ovary syndrome	3.05e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.04e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.04e-06	1.41e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.99e-06	1.39e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.98e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.98e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.98e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.97e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	2.96e-06	1.38e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	2.96e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.95e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	2.95e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	2.95e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—AKT2—polycystic ovary syndrome	2.95e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—AKT2—polycystic ovary syndrome	2.95e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling by GPCR—IL6—polycystic ovary syndrome	2.94e-06	1.37e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	2.93e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	2.92e-06	1.36e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	2.91e-06	1.35e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—SERPINE1—polycystic ovary syndrome	2.89e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	2.89e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—INS—polycystic ovary syndrome	2.89e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—BCL2—polycystic ovary syndrome	2.88e-06	1.34e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—MTHFR—polycystic ovary syndrome	2.87e-06	1.33e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	2.84e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.84e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.84e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	2.83e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	2.83e-06	1.32e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	2.83e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.83e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.82e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	2.81e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.81e-06	1.31e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.81e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.8e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—SERPINE1—polycystic ovary syndrome	2.8e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—SERPINE1—polycystic ovary syndrome	2.8e-06	1.3e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—BCL2—polycystic ovary syndrome	2.79e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—BCL2—polycystic ovary syndrome	2.79e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.78e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.77e-06	1.29e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.76e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	2.75e-06	1.28e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.73e-06	1.27e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.72e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	2.72e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	2.71e-06	1.26e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	2.7e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	2.7e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.69e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PPARG—polycystic ovary syndrome	2.69e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	2.68e-06	1.25e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.67e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.67e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	2.67e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	2.67e-06	1.24e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	2.66e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	2.66e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—INS—polycystic ovary syndrome	2.66e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—POMC—polycystic ovary syndrome	2.65e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	2.65e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	2.65e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.65e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.65e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	2.64e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IRS2—polycystic ovary syndrome	2.64e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—INS—polycystic ovary syndrome	2.64e-06	1.23e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	2.64e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.63e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	2.62e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.62e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	2.62e-06	1.22e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.61e-06	1.21e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	2.61e-06	1.21e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.61e-06	1.21e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	2.61e-06	1.21e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.6e-06	1.21e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	2.6e-06	1.21e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PPARG—polycystic ovary syndrome	2.6e-06	1.21e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PPARG—polycystic ovary syndrome	2.6e-06	1.21e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—LEP—polycystic ovary syndrome	2.58e-06	1.2e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.57e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.57e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—POMC—polycystic ovary syndrome	2.57e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—POMC—polycystic ovary syndrome	2.57e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.57e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.56e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Innate Immune System—IL6—polycystic ovary syndrome	2.56e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.56e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.56e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.55e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.55e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—INS—polycystic ovary syndrome	2.55e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—INS—polycystic ovary syndrome	2.55e-06	1.19e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	2.55e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	2.55e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2.54e-06	1.18e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	2.53e-06	1.17e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.52e-06	1.17e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.52e-06	1.17e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.52e-06	1.17e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.52e-06	1.17e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.51e-06	1.17e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.51e-06	1.17e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—LEP—polycystic ovary syndrome	2.5e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—LEP—polycystic ovary syndrome	2.5e-06	1.16e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.48e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Innate Immune System—IL6—polycystic ovary syndrome	2.48e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Innate Immune System—IL6—polycystic ovary syndrome	2.48e-06	1.15e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.44e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.44e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	2.43e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.43e-06	1.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.42e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	2.42e-06	1.12e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.4e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.4e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.39e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.38e-06	1.11e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.37e-06	1.1e-05	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—IL6—polycystic ovary syndrome	2.35e-06	1.09e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	2.34e-06	1.09e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	2.34e-06	1.09e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PPARG—polycystic ovary syndrome	2.33e-06	1.08e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IRS1—polycystic ovary syndrome	2.3e-06	1.07e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—POMC—polycystic ovary syndrome	2.29e-06	1.07e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—INS—polycystic ovary syndrome	2.28e-06	1.06e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.28e-06	1.06e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.27e-06	1.05e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.26e-06	1.05e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.26e-06	1.05e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.25e-06	1.05e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.23e-06	1.04e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IRS1—polycystic ovary syndrome	2.23e-06	1.04e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.23e-06	1.04e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.22e-06	1.03e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—POMC—polycystic ovary syndrome	2.22e-06	1.03e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—INS—polycystic ovary syndrome	2.21e-06	1.02e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.19e-06	1.02e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.17e-06	1.01e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.15e-06	1e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—POMC—polycystic ovary syndrome	2.15e-06	9.97e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—POMC—polycystic ovary syndrome	2.15e-06	9.97e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—INS—polycystic ovary syndrome	2.13e-06	9.91e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—INS—polycystic ovary syndrome	2.13e-06	9.91e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IGF1—polycystic ovary syndrome	2.13e-06	9.91e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—AKT2—polycystic ovary syndrome	2.13e-06	9.9e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.06e-06	9.59e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IGF1—polycystic ovary syndrome	2.06e-06	9.59e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—AKT2—polycystic ovary syndrome	2.06e-06	9.58e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.06e-06	9.58e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.06e-06	9.57e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	2.04e-06	9.47e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.03e-06	9.41e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—POMC—polycystic ovary syndrome	2.01e-06	9.34e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.01e-06	9.32e-06	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—INS—polycystic ovary syndrome	2e-06	9.29e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	2e-06	9.28e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.97e-06	9.13e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.96e-06	9.11e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.96e-06	9.11e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.96e-06	9.11e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.96e-06	9.08e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.95e-06	9.05e-06	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.94e-06	9.03e-06	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.93e-06	8.98e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.93e-06	8.97e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.93e-06	8.94e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.92e-06	8.92e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.89e-06	8.8e-06	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.88e-06	8.75e-06	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.85e-06	8.6e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.84e-06	8.55e-06	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—IL6—polycystic ovary syndrome	1.82e-06	8.44e-06	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—IL6—polycystic ovary syndrome	1.81e-06	8.43e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.79e-06	8.31e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.75e-06	8.14e-06	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—IL6—polycystic ovary syndrome	1.74e-06	8.07e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.71e-06	7.93e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.68e-06	7.8e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.68e-06	7.78e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.67e-06	7.76e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.66e-06	7.73e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.66e-06	7.72e-06	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—IL6—polycystic ovary syndrome	1.66e-06	7.7e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.65e-06	7.66e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.64e-06	7.64e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.63e-06	7.58e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.63e-06	7.56e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.61e-06	7.46e-06	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.6e-06	7.41e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.58e-06	7.33e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.58e-06	7.33e-06	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—IL6—polycystic ovary syndrome	1.56e-06	7.26e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.55e-06	7.19e-06	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	1.54e-06	7.16e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.53e-06	7.1e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—IL6—polycystic ovary syndrome	1.49e-06	6.93e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—IL6—polycystic ovary syndrome	1.44e-06	6.7e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—IL6—polycystic ovary syndrome	1.44e-06	6.7e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.39e-06	6.47e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—IL6—polycystic ovary syndrome	1.38e-06	6.39e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.35e-06	6.26e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.35e-06	6.26e-06	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.34e-06	6.24e-06	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.34e-06	6.21e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—IL6—polycystic ovary syndrome	1.33e-06	6.19e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—IL6—polycystic ovary syndrome	1.33e-06	6.19e-06	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.28e-06	5.95e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.26e-06	5.83e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.24e-06	5.75e-06	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.23e-06	5.72e-06	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	1.18e-06	5.48e-06	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.16e-06	5.39e-06	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	1.16e-06	5.38e-06	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	1.16e-06	5.37e-06	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	1.15e-06	5.35e-06	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	1.14e-06	5.3e-06	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.14e-06	5.28e-06	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.06e-06	4.91e-06	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IL6—polycystic ovary syndrome	9.64e-07	4.48e-06	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IL6—polycystic ovary syndrome	9.33e-07	4.33e-06	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IL6—polycystic ovary syndrome	9.33e-07	4.33e-06	CbGpPWpGaD
